Pulmonx (LUNG)CHIEF COMMERCIAL OFFICER sold ~$2.9K
Geoffrey Beran Rose, CHIEF COMMERCIAL OFFICER at Pulmonx, sold ~$2.9K of Pulmonx shares.
- ~$2.9K
- Approx. value · 1,799 sh @ $1.60
- 384K
- Holds after · shares reported
- Traded
- Sep 2, 2025
- Filed
- Sep 3, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 2, 2025 · this disclosureInsiderOfficer sold ~$2.9K of LUNG shares in the open market
What came next
- Sep 2, 2025Insider · 4 peopleInsiders: 11 sales (~$51K)
- Oct 17, 2025Federal contract · $20K obligatedDepartment of Veterans Affairs awarded Pulmonx Corp: $20K obligated to date
- Oct 21, 2025Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On October 21, 2025, Steven S. Williamson resigned as President and Chief Executive Officer and a member of the Board of Directors of Pulmonx Corporation (the “Company”), effective as of October 27, 2025 (the “Effective Date”).”
- Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 19, 2025Federal contract · $19K obligatedDepartment of Veterans Affairs awarded Pulmonx Corp: $19K obligated to date
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Pulmonx
OQRO holds no insider, Congress, fund or contract record for Pulmonx dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LUNG page.
Other recent filings by Geoffrey Beran Rose, CHIEF COMMERCIAL OFFICER
- SEC Form 4 at Pulmonx (LUNG)Sep 3, 2025
- SEC Form 4 at Pulmonx (LUNG)Sep 3, 2025
- SEC Form 4 at Pulmonx (LUNG)Sep 3, 2025
- SEC Form 4 at Pulmonx (LUNG)Jun 4, 2025
- SEC Form 4 at Pulmonx (LUNG)Jun 4, 2025
The full history of Geoffrey Beran Rose, CHIEF COMMERCIAL OFFICER is on the profile page.
How this filing works
Other disclosures at Pulmonx
- USAspending.gov award recordJun 26, 2026
- USAspending.gov award recordNov 19, 2025
- USAspending.gov award recordOct 17, 2025
- SEC Form 4Sep 3, 2025
- SEC Form 4Sep 3, 2025
- SEC Form 4Sep 3, 2025
Everything OQRO holds on this company is on its LUNG page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
